Johnson & Johnson and its subsidiaries have approximately 152,700 employees worldwide engaged in the research and development, manufacture, and sale of a broad range of products in the healthcare field. The company is committed to creating value by developing accessible, high-quality, innovative products and services, which reflects its focus on maintaining operational flexibility and adaptability in response to the evolving demands of the healthcare market. Management emphasizes the importance of leveraging extensive resources across the enterprise to innovate and execute with excellence, ensuring the company can remain focused on addressing the unmet needs of society and invest for an enduring impact. The company's purpose is to blend heart, science, and ingenuity to profoundly change the trajectory of health for humanity, indicating a strategic orientation toward resilience in the face of external pressures and market volatility. 

In 2022, the company invested $14.6 billion in research and development, demonstrating a commitment to creating life-enhancing innovations and fostering organizational capabilities that support resilience strategies. The diversity of its workforce empowers employees to lead with agility and urgency, which is essential for navigating unexpected situations and maintaining performance under pressure. The company has achieved approximately $0.8 billion in annual pre-tax cost savings through restructuring actions aimed at enhancing agility and driving growth, reflecting a proactive approach to resource allocation and operational management.

The company continues to monitor its internal and external supply arrangements, particularly in light of the challenges posed by environmental disruptions and inflationary pressures. The strategic initiatives undertaken by the company, including the separation of its consumer health business, are designed to optimize resource deployment and enhance organizational coherence. The company’s performance has been impacted by various factors, including competitive pressures and supply constraints, which necessitate a focus on resilience and adaptability to ensure sustained growth and operational continuity.

The company has also taken steps to address the implications of the ongoing geopolitical situation, including the suspension of certain operations in Russia while continuing to supply essential healthcare products. This reflects an understanding of the need for crisis management and emergency preparedness in maintaining organizational health and effectiveness. The company’s approach to risk management includes evaluating and adjusting its operational strategies to mitigate the impact of external disturbances and ensure long-term sustainability.

Overall, Johnson & Johnson's strategic focus on innovation, resourcefulness, and operational flexibility underscores its commitment to organizational resilience, enabling it to confront challenges and adapt to the dynamic healthcare landscape while striving for continued success and growth.